The ROSI study (risedronate in adults with osteogenesis imperfecta type 1)

The ROSI study (risedronate in adults with osteogenesis imperfecta type 1)

Bibliographic Details
Main Authors:	Duncan, E, Bradbury, L, Barlow, S, Geoghenan, F, Blumsohn, A, Schofield, P, Wass, J, Russell, R, Brown, M
Format:	Conference item
Published:	2005

Similar Items

The ROSI study (Risedronate in adults with osteogenesis imperfecta type 1): Improved BMD but high fracture rate persists.
by: Bradbury, L, et al.
Published: (2006)

Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists.
by: Bradbury, L, et al.
Published: (2012)

Calcitonin in osteogenesis imperfecta.
by: Smith, R, et al.
Published: (1973)

Cardiovascular abnormalities in osteogenesis imperfecta.
by: White, N, et al.
Published: (1983)

Valuation of lost productivity of adults with X-linked Hypophosphataemia and Osteogenesis imperfecta
by: Cole, S, et al.
Published: (2023)

Molecular and Mesoscale Mechanisms of Osteogenesis Imperfecta Disease
by: Uzel, Sebastien Guy Marcel, et al.
Published: (2011)

Osteogenesis imperfecta is linked to both type I collagen structural genes.
by: Sykes, B, et al.
Published: (1986)

CONSISTENT LINKAGE OF DOMINANTLY INHERITED OSTEOGENESIS IMPERFECTA TO COLLAGEN-1 GENES
by: Sykes, B, et al.
Published: (1988)

Hospital admissions of patients with osteogenesis imperfecta in the English NHS
by: Kolovos, S, et al.
Published: (2021)

Molecular and Mesoscale Mechanisms of Osteogenesis Imperfecta Disease in Collagen Fibrils
by: Gautieri, Alfonso, et al.
Published: (2015)

Description of hospital use by patients with osteogenesis imperfecta in the English NHS
by: Kolovos, S, et al.
Published: (2020)

Conceptualization and validation of a health economic model for osteogenesis imperfecta
by: Edmonds, T, et al.
Published: (2024)

Physical function in UK adults with osteogenesis imperfecta: a cross-sectional analysis of the RUDY study
by: Orlando, G, et al.
Published: (2020)

TYPE-I COLLAGEN STRUCTURAL GENES IN OSTEOGENESIS IMPERFECTA AND OTHER HERITABLE DISORDERS OF CONNECTIVE-TISSUE
by: Wordsworth, B, et al.
Published: (1987)

Potential of human fetal chorionic stem cells for the treatment of osteogenesis imperfecta.
by: Jones, G, et al.
Published: (2014)

Structure–mechanics relationships of collagen fibrils in the osteogenesis imperfecta mouse model
by: Andriotis, O. G., et al.
Published: (2016)

Consistent linkage of dominantly inherited osteogenesis imperfecta to the type I collagen loci: COL1A1 and COL1A2.
by: Sykes, B, et al.
Published: (1990)

Valuation of lost productivity for people with osteogenesis imperfecta: preliminary results from the RUDY cohort
by: Cole, SE, et al.
Published: (2022)

Estimating the benefits of reduced fracture incidence for patients living with osteogenesis imperfecta and for healthcare payers
by: Edmonds, T, et al.
Published: (2024)

Lethal osteogenesis imperfecta and a collagen gene deletion. Length polymorphism provides an alternative explanation.
by: Sykes, B, et al.
Published: (1985)

Estimating the burden of osteogenesis imperfecta on patients and healthcare payers: a health economic modelling study
by: Edmonds, T, et al.
Published: (2024)

Whole Exome Sequencing is a Sensitive and Cost-Effective Means of Detecting Mutations in Patients with Marfan Syndrome and Osteogenesis Imperfecta
by: Duncan, E, et al.
Published: (2013)

Health-related quality of life and a cost-utility simulation of adults in the UK with osteogenesis imperfecta, X-linked hypophosphatemia and fibrous dysplasia
by: Forestier-Zhang, L, et al.
Published: (2016)

Elucidation of proteostasis defects caused by osteogenesis imperfecta mutations in the collagen-α2(I) C-propeptide domain
by: Doan, Ngoc-Duc, et al.
Published: (2021)

Transplantation of human fetal blood stem cells in the osteogenesis imperfecta mouse leads to improvement in multiscale tissue properties.
by: Vanleene, M, et al.
Published: (2011)

Elucidation of proteostasis defects caused by osteogenesis imperfecta mutations in the collagen-α2(I) C-propeptide domain
by: Doan, Ngoc Duc, et al.
Published: (2022)

Novel mutation G324C in WNT1 mapped in a large Pakistani family with severe recessively inherited Osteogenesis Imperfecta
by: Kausar, Mehran, et al.
Published: (2019)

Valuation of lost productivity for individuals diagnosed with Osteogenesis imperfecta: follow-up findings from the Rudy Cohort Study in the UK
by: Cole, S, et al.
Published: (2022)

Four patients with Sillence type I osteogenesis imperfecta and mild bone fragility, complicated by left ventricular cardiac valvular disease and cardiac tissue fragility caused by type I collagen mutations.
by: Vandersteen, A, et al.
Published: (2014)

Four patients with Sillence type I osteogenesis imperfecta and mild bone fragility, complicated by left ventricular cardiac valvular disease and cardiac tissue fragility caused by type I collagen mutations
by: Vandersteen, A, et al.
Published: (2013)

Fibrogenesis imperfecta ossium.
by: Carr, A, et al.
Published: (1995)

Studies to elucidate the anti-tumor mechanism of action of risedronate in human myeloma cells; Use of an analogue of risedronate reveals the effects of differential inhibition of prenylation
by: Roelofs, A, et al.
Published: (2005)

Intrauterine transplantation of human fetal mesenchymal stem cells from first-trimester blood repairs bone and reduces fractures in osteogenesis imperfecta mice.
by: Guillot, P, et al.
Published: (2008)

A rare heterozygous SP7 variant c.1019A>c (p.Glu340Ala) in a Malaysian family with Osteogenesis Imperfecta Type XII: a case report
by: Teh, Hui Wen, et al.
Published: (2024)

Fluorescently labeled risedronate and related analogues: "magic linker" synthesis.
by: Kashemirov, B, et al.
Published: (2008)

Amelogenesis Imperfecta; Genes, Proteins, and Pathways.
by: Smith, C, et al.
Published: (2017)

Synthesis and biological evaluation of alpha-halogenated bisphosphonate and phosphonocarboxylate analogues of risedronate.
by: Marma, MS, et al.
Published: (2007)

Fluorescently labeled risedronate and related analogs: Design and evaluation as imaging probes
by: Coxon, F, et al.
Published: (2008)

Fluorescently labeled risedronate and related analocs: Design and evaluation as imaging probes
by: Coxon, F, et al.
Published: (2008)

Classical solutions of yang-mills-chern-simons theory in 2+1 dimensions : a quasi-linear superposition / Rosy Teh
by: Teh, Rosy
Published: (1994)